Skip to main content

Table 1 Treatment and neonatal short-term outcome of 17 Pregnancies with maternal toxoplasma infection. SGA small for gestational age

From: The impact of socioeconomic factors on the efficiency of voluntary toxoplasmosis screening during pregnancy: a population-based study

Newborn

GA AT infection (weeks)

Mother IGM

Mother IGG

Avidity

Treatment spiramycin

Newborn IGG

Newborn IGM

Findings in the fetus

Treatment newborn

1

6

+

+

no

+

-

-

no

no

2

8

+

+

no

+

-

-

no

no

3

8

+

+

low

+

+

-

SGA

yes

4

8

+

+

low

+

+

+a

no

yes

5

10

+

+

low

?

+

-

no

no

6

10

+

+

low

-

+

IgG increaseda

-

Cerebral ventricular dilatation

yes

7

11

+

+

low

+

+

-

no

no

8

12

+

+

low

inadequate

-

-

SGA

no

9

12

+

+

low

+

+

+a

SGA

yes

10

14

+

+

high

+

+

-a

-

no

no

11

16

+

+

low

-

+

+

Cerebral Disorders

yes

12

17

+

+

low

+

+

-

no

no

13

No informatio

+

+

low

+

+

-

no

no

14

No information

+

+

low

No information

+

-

no

no

15

No information

+

+

low

No information

+

-

no

no

16b

20

+

+

no

-

+

+

SGA

yes

17b

21

+

+

no

-

+

+

SGA

yes

  1. aat repeated blood sampling, bNewborn 16 and 17: detected at the second screening